New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has demonstrated that OGM provided reliable and robust analytical performance with high ...

An Oxford-developed single-allele chromatin mapping platform called MCCv identifies causal noncoding variants in autoimmune ...

Standard laboratory tests can fail to detect many disease-causing DNA changes. Now, a novel 3D chromosome mapping method can reliably reveal these hidden structural variants and lead to new ...

Scientists have sequenced the complete genome of a roundworm used extensively in biological research, opening a new pathway for synthetic biologists to build and test genetic changes in a ...

Increasing usage of optical genome mapping for drug discovery is providing significant growth opportunities for the market, aiding the pharmaceutical companies in comprehensive structural variation ...

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based ...

Separate studies led by scientists at Dartmouth Hitchcock Medical Center (DMHC) and Queens University offer some clarity about the hidden causes of recurrent pregnancy loss. Data from both studies is ...

Former Bionano Genomics Chief Medical Officer joins Nabsys at a pivotal moment as the Company expands commercialization of its electronic genome mapping platform Dr. Chaubey will lead medical and ...

The retrospective analysis of more than 650 pediatric patients with ID/DD demonstrated that WGS identified a genetic diagnosis in 31.1% of children overall, with the diagnostic yield reaching 35.3% ...

Chinese researchers have developed a technology that sheds light on how the three-dimensional (3D) organization of plant genomes influences gene expression—especially in photosynthesis. The research, ...